← Eichor
Condition: Vasomotor Symptoms Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Vasomotor Symptoms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clin
Phase N/A · 2 location(s) · Astellas Pharma Europe Ltd. · NCT07602530Hot Flashes and Neurovascular Function in Women
NA · 1 location(s) · Mayo Clinic · NCT05193968Prevalence of Menopause-associated Symptoms Throughout the Menopausal Transition in Women Aged 40 to 70 Residing in Spai
Phase N/A · 2 location(s) · Cuerpos Serranos S.L. · NCT07596069FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endo
Phase 2 · 2 location(s) · Yale University · NCT06917313The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health.
NA · 1 location(s) · Leeds Beckett University · NCT07135232Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
Phase 2 · 1 location(s) · University of Vermont · NCT06972875Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
NA · 1 location(s) · Inova Health Care Services · NCT07335224Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).
Phase 2 · 1 location(s) · Tioga Pharmaceuticals · NCT07042516No More Sleepless Nights in Perimenopause
Phase 4 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06497894Impact of Lean Pork on Endothelial Function in Perimenopause
NA · 1 location(s) · Pennington Biomedical Research Center · NCT06976112A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms i
NA · 1 location(s) · University of Virginia · NCT07535541The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
Phase 4 · 1 location(s) · Mayo Clinic · NCT07218445A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women
Phase N/A · 1 location(s) · IdentifyHer Limited · NCT07022925Efficacy of Nano-Pso Therapy in Menopause
NA · 1 location(s) · Distribuidora Biolife SA de CV · NCT06432816Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women
NA · 2 location(s) · Linkoeping University · NCT06030388A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists W
NA · 1 location(s) · Olly, PBC · NCT07033013Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause
NA · 1 location(s) · ApexCPG LLC · NCT07112651JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
NA · 1 location(s) · Bonafide Health · NCT07238478Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Pro
Phase 2 · 1 location(s) · Shehzad Basaria, M.D. · NCT06957691
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.